Burden of disease and costs of exposure to endocrine disrupting chemicals in the European Union: an updated analysis

Abstract

SUMMARY A previous report documented that endocrine disrupting chemicals contribute substantially to certain forms of disease and disability. In the present analysis, our main objective was to update a range of health and economic costs that can be reasonably attributed to endocrine disrupting chemical exposures in the European Union, leveraging new burden and disease cost estimates of female reproductive conditions from accompanying report. Expert panels evaluated the epidemiologic evidence, using adapted criteria from the WHO Grading of Recommendations Assessment, Development and Evaluation Working Group, and evaluated laboratory and animal evidence of endocrine disruption using definitions recently promulgated by the Danish Environmental Protection Agency. The Delphi method was used to make decisions on the strength of the data. Expert panels consensus was achieved for probable (>20%) endocrine disrupting chemical causation for IQ loss and associated intellectual disability; autism; attention deficit hyperactivity disorder; endometriosis; fibroids; childhood obesity; adult obesity; adult diabetes; cryptorchidism; male infertility, and mortality associated with reduced testosterone. Accounting for probability of causation, and using the midpoint of each range for probability of causation, Monte Carlo simulations produced a median annual cost of €163 billion (1.28% of EU Gross Domestic Product) across 1000 simulations. We conclude that endocrine disrupting chemical exposures in the EU are likely to contribute substantially to disease and dysfunction across the life course with costs in the hundreds of billions of Euros per year. These estimates represent only those endocrine disrupting chemicals with the highest probability of causation; a broader analysis would have produced greater estimates of burden of disease and costs.

Autism genes are selectively targeted by environmental pollutants including pesticides, heavy metals, bisphenol A, phthalates and many others in food, cosmetics or household products

“…Many of these compounds are endocrine disruptors which have been linked to a variety of diseases, including autism, attention hyperactivity deficit disorder, obesity and diabetes, whose incidence has increased in recent decades. Their annual burden of health cost in the European Union has been estimated at over 100 billion Euros [7,8] .…”

Larger Than Life: Injecting Hope into the Planetary Health Paradigm

“…For example, organophosphate pesticides help 'feed the world' by improving crop yields; but volumes of research demonstrate detrimental effects on health, including interference with normal brain development-these and other endocrine disrupting chemicals ultimately cost society hundreds of billions of dollars [194]. However, when clear evidence indicates that a particular pesticide should be removed from agricultural use, politics and profits stand in the way; scientists who speak up are subsequently labeled as 'pseudoscientists' and 'anti-technologists' [195].…”

Human environmental disease network: A computational model to assess toxicology of contaminants

“…Crossing the hypotheses made by our approach with some other observations described in the literature could further improve the characterization of potential chemical-disease relationships. For example, a group led by Leonardo Trasande has recently developed a system to estimate health and economic costs related to endocrine disrupting chemicals (EDCs) exposure in the European Union (Trasande et al, 2015(Trasande et al, , 2016 and the USA (Attina et al, 2016). To estimate costs, they used available epidemiological and toxicological evidence for each EDC and weighted them.…”